Harmony Biosciences Holdings Inc

HRMY11 Dec 2024
Healthcare
$33.47
-0.02 (-2.30%)
Lowest Today
$32.41
Highest Today
$33.47
Today’s Open
$33.47
Prev. Close
$33.48
52 Week High
$41.61
52 Week Low
$28.14
To Invest in Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Healthcare
HRMY11 Dec 2024
-0.02 (-2.30%)
1M
3M
6M
1Y
5Y
Low
$32.41
Day’s Range
High
$33.47
32.41
52 Week Low
$28.14
52-Week Range
52 Week High
$41.61
28.14
1 Day
-
1 Week
-6.35%
1 month return
-8.97%
3 month return
-12.47%
6 month return
+9.99%
1 Year return
+5.45%
3 Years return
-14.51%
5 Years return
-
10 Years return
-
Institutional Holdings
Valor Management LLC
19.67
BlackRock Inc
10.23
FMR Inc
9.17
Vanguard Group Inc
6.09
Vivo Capital, LLC
4.57
iShares Core S&P Small-Cap ETF
4.32
Fidelity Growth Compy Commingled Pl S
4.28

Market Status

Fundamentals
Market Cap
1909.41 mln
PB Ratio
3.23
PE Ratio
15.87
Enterprise Value
1697.75 mln
Total Assets
811.45 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
Organisation
Harmony Biosciences Holdings Inc
Employees
246
Industry
Biotechnology
CEO
Dr. Jeffrey M. Dayno M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities